Form D · Other Health Care

RxWare, Inc.

Wilmington, DE · CIK 0001790134

Offering snapshot reported Aug 14, 2025 · SEC filing

Reported sold
$6.14M
Offering amount: $6.74M
Investors reported
12
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Aug 1, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 14, 2025Initial$6,144,268No comparison12SEC filing
Dec 2, 2024Initial$225,000No comparison3SEC filing
May 7, 2024Initial$700,000No comparison4SEC filing
Oct 4, 2019Initial$3,620,000No comparison4SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
$0
Finders' fees
$0
Form D file number
021-554698
Amounts include conversion of outstanding convertible notes and simple agreements for future equity. In addition, the Company has offered 10-year warrants to purchase up to a maximum of 101,891 shares at $2.9443 per share.

Source: Form D, filed Aug 14, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Shlomi Aflalo Director, Executive
Farhan Ashraf Director
Gregg Dearhammer Director
Adam Fine Director
Aaron Ganz Executive
Ori Karev Director
Yishai Knobel Director, Executive
Raeanna Lewarne Director, Executive
David Matias Director
Harry Totonis Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1313 North Market Street Suite 1000
Wilmington, DE, 19801